MCT1 as molecularly validated predictive marker for lenalidomide-maintenance therapy in multiple myeloma - Stroh, Jacob; Seckinger, Anja; Heider, Michael; Eichner, Ruth; Emde-Rajaratnam, Martina; Salwender, Hans; Bertsch, Uta; Goldschmidt, Hartmut; Weisel, Katja; Scheid, Christoph; Hose, Dirk; Bassermann, Florian (Blood, 2019)
Gesehen am 07.08.2024